NorthRock Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Buy |
14,419
+1,098
| +8% | +$856K | 0.29% | 47 |
|
|
2025
Q1 | $11M | Buy |
13,321
+299
| +2% | +$247K | 0.37% | 35 |
|
|
2024
Q4 | $10.1M | Sell |
13,022
-222
| -2% | -$171K | 0.33% | 44 |
|
|
2024
Q3 | $11.7M | Buy |
13,244
+236
| +2% | +$209K | 0.39% | 35 |
|
|
2024
Q2 | $11.8M | Buy |
13,008
+669
| +5% | +$606K | 0.44% | 33 |
|
|
2024
Q1 | $9.6M | Buy |
12,339
+622
| +5% | +$484K | 0.37% | 40 |
|
|
2023
Q4 | $6.83M | Buy |
11,717
+6,543
| +126% | +$3.81M | 0.29% | 50 |
|
|
2023
Q3 | $2.78M | Buy |
5,174
+1,119
| +28% | +$601K | 0.29% | 40 |
|
|
2023
Q2 | $1.9M | Sell |
4,055
-341
| -8% | -$160K | 0.21% | 50 |
|
|
2023
Q1 | $1.51M | Sell |
4,396
-786
| -15% | -$270K | 0.16% | 61 |
|
|
2022
Q4 | $1.9M | Buy |
5,182
+1,043
| +25% | +$382K | 0.22% | 49 |
|
|
2022
Q3 | $1.34M | Buy |
4,139
+217
| +6% | +$70.1K | 0.16% | 68 |
|
|
2022
Q2 | $1.27M | Buy |
3,922
+266
| +7% | +$86.3K | 0.13% | 79 |
|
|
2022
Q1 | $1.05M | Sell |
3,656
-287
| -7% | -$82.2K | 0.09% | 97 |
|
|
2021
Q4 | $1.09M | Buy |
3,943
+1,166
| +42% | +$322K | 0.08% | 96 |
|
|
2021
Q3 | $642K | Buy |
2,777
+524
| +23% | +$121K | 0.05% | 129 |
|
|
2021
Q2 | $517K | Buy |
2,253
+674
| +43% | +$155K | 0.04% | 134 |
|
|
2021
Q1 | $295K | Buy |
1,579
+99
| +7% | +$18.5K | 0.03% | 179 |
|
|
2020
Q4 | $250K | Sell |
1,480
-293
| -17% | -$49.5K | 0.02% | 188 |
|
|
2020
Q3 | $262K | Buy |
1,773
+195
| +12% | +$28.8K | 0.03% | 178 |
|
|
2020
Q2 | $259K | Sell |
1,578
-425
| -21% | -$69.8K | 0.03% | 173 |
|
|
2020
Q1 | $278K | Sell |
2,003
-2,707
| -57% | -$376K | 0.04% | 148 |
|
|
2019
Q4 | $619K | Buy |
+4,710
| New | +$619K | 0.07% | 132 |
|